髙橋 宏通

医学部 医学科准教授

プロモーション

  • プロフィール

    医療・健康, 血液内科、腫瘍内科、臨床検査医学、腫瘍免疫学, 臨床、教育、研究を行い、より良い医療の提供と開発を目指します。

学位

  • 医学博士, 日本大学医学部大学院

研究キーワード

  • 腫瘍微小環境
  • 腫瘍関連マクロファージ
  • リンパ腫

研究分野

  • ライフサイエンス, 血液、腫瘍内科学, 血液内科学

経歴

  • 2022年10月 - 現在
    日本大学医学部内科学系血液膠原病内科学分野
  • 2015年02月 - 2022年09月
    日本大学医学部病態病理学系臨床検査医学分野
  • 2015年02月01日
    日本大学医学部病態病理学系臨床検査医学分野

学歴

  • 2009年04月 - 2013年03月
    日本大学, 医学部, 内科学系分野血液内科
  • 2001年04月 - 2007年03月
    日本大学, 医学部, 医学科

論文

  • Topological importance of CD8+ T-cell enrichment in the tumor microenvironment of classic Hodgkin lymphoma.
    Hiromichi Takahashi; Shun Ito; Yoko Nakanishi; Katsuhiro Miura; Haruna Nishimaki; Masaru Nakagawa; Shimon Otake; Takashi Hamada; Takashi Koike; Kazuhide Iizuka; Shinobu Masuda; Tomohiro Nakayama; Tetsuo Shimizu; Naoya Ishibashi; Hirofumi Kogure; Hideki Nakamura
    Annals of hematology, 2025年01月
  • TAFRO Syndrome: Guidance for Managing Patients Presenting Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly.
    Katsuhiro Miura; Haruna Nishimaki-Watanabe; Hiromichi Takahashi; Masaru Nakagawa; Shimon Otake; Takashi Hamada; Takashi Koike; Kazuhide Iizuka; Yuuichi Takeuchi; Kazuya Kurihara; Toshihide Endo; Shun Ito; Hironao Nukariya; Takahiro Namiki; Yoshiyuki Hayashi; Hideki Nakamura
    Biomedicines, 2024年06月
  • Use of finer needles for venipuncture increases in vitro haemolysis despite reducing persistent pain and nerve injury: a retrospective study.
    Hiroshi Umemura; Hiromichi Takahashi; Yoshiaki Fukuda; Hitoshi Soma; Rumiko Aoki; Norihisa Takei; Tomohiro Nakayama
    Annals of clinical biochemistry, 2023年08月
  • Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience.
    Noriyoshi Iriyama; Katsuhiro Miura; Hiromichi Takahashi; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Takashi Koike; Kazuya Kurihara; Toshihide Endo; Tomohiro Nakayama; Yoshihiro Hatta; Hideki Nakamura
    Leukemia & lymphoma, 2023年01月
  • [Thrombotic microangiopathy with gastrointestinal hemorrhage during carfilzomib therapy for multiple myeloma].
    Shuhei Matsumoto; Hiromichi Takahashi; Takashi Hamada; Katsuhiro Miura; Masaru Nakagwa; Kazuya Kurihara; Toshihide Endo; Takashi Koike; Kazuhide Iizuka; Noriyoshi Iriyama; Tomohiro Nakayama; Yoshihiro Hatta; Hideki Nakamura
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2023年
  • Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation.
    Takashi Hamada; Hiromichi Takahashi; Masaru Nakagawa; Hironao Nukariya; Shun Ito; Toshihide Endo; Kazuya Kurihara; Takashi Koike; Kazuhide Iizuka; Shimon Ohtake; Takashi Ichinohe; Toshiya Maebayashi; Katsuhiro Miura; Yoshihiro Hatta; Hideki Nakamura
    Case reports in oncology, 2023年
  • Pirarubicin-based intensive chemotherapy followed by consolidative high-dose chemotherapies for peripheral T-cell lymphomas: A noncomparative phase 2 study.
    Hiromichi Takahashi; Katsuhiro Miura; Masaru Nakagawa; Haruna Nishimaki; Shun Ito; Hironao Nukariya; Kazuya Kurihara; Toshihide Endo; Takashi Koike; Takashi Hamada; Kazuhide Iizuka; Shimon Ohatake; Noriyoshi Iriyama; Tomohiro Nakayama; Shinobu Masuda; Yoshihiro Hatta; Hideki Nakamura
    Hematological oncology, 2022年12月
  • Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma.
    Katsuhiro Miura; Hiromichi Takahashi; Masaru Nakagawa; Takashi Hamada; Yoshihito Uchino; Kazuhide Iizuka; Shimon Ohtake; Noriyoshi Iriyama; Yoshihiro Hatta; Hideki Nakamura
    Expert review of anticancer therapy, 2022年06月
  • Clinical impact of central nervous system-directed therapies on intravascular large B-cell lymphoma: A single institution's experience.
    Hiromichi Takahashi; Haruna Nishimaki; Yoko Nakanishi; Takashi Hamada; Masaru Nakagawa; Kazuhide Iizuka; Yoshihito Uchino; Noriyoshi Iriyama; Katsuhiro Miura; Tomohiro Nakayama; Shinobu Masuda; Yoshihiro Hatta; Hideki Nakamura
    EJHaem, 2022年05月
  • Relationship between Carnitine Deficiency and Tyrosine Kinase Inhibitor Use in Patients with Chronic Myeloid Leukemia.
    Noriyoshi Iriyama; Katsuhiro Miura; Yoshihito Uchino; Hiromichi Takahashi; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Takashi Koike; Kazuya Kurihara; Tomohiro Nakayama; Masami Takei; Yoshihiro Hatta; Hideki Nakamura
    Chemotherapy, 2021年11月
  • Efficacy of introducing electronic cigarettes in smoker's polycythemia(和訳中)
    飯塚 和秀; 伊藤 駿; 忽滑谷 寛直; 遠藤 聖英; 栗原 一也; 小池 隆; 濱田 高志; 中川 優; 内野 慶人; 高橋 宏通; 三浦 勝浩; 入山 規良; 八田 善弘; 中山 智祥; 武井 正美
    日本血液学会学術集会, 2021年09月
  • 新規治療薬時代以降に診断された多発性骨髄腫患者における治療モダリティーと予後の変遷
    吉田 努; 入山 規良; 内野 慶人; 高橋 宏通; 中川 優; 濱田 高志; 飯塚 和秀; 小池 隆; 栗原 一也; 遠藤 聖英; 野口 夕利花; 三浦 勝浩; 八田 善弘; 中山 智祥; 武井 正美
    日大医学雑誌, 2021年02月
  • Absolute Lymphocyte Counts After Lenalidomide Initiation may Predict the Prognosis of Patients With Relapsed or Refractory Multiple Myeloma.
    Masaru Nakagawa; Noriyoshi Iriyama; Takuto Ishikawa; Katsuhiro Miura; Yoshihito Uchino; Hiromichi Takahashi; Takashi Hamada; Kazuhide Iizuka; Takashi Koike; Kazuya Kurihara; Tomohiro Nakayama; Yoshihiro Hatta; Masami Takei
    Cancer diagnosis & prognosis, 2021年
  • Maintenance Therapy With Bortezomib and Dexamethasone for Transplant-ineligible Patients With Multiple Myeloma.
    Yurika Noguchi; Noriyoshi Iriyama; Hiromichi Takahashi; Yoshihito Uchino; Masaru Nakagawa; Takashi Hamada; Kazuhide Iizuka; Takashi Koike; Kazuya Kurihara; Toshihide Endo; Tsutomu Yoshida; Katsuhiro Miura; Tomohiro Nakayama; Yoshihiro Hatta; Masami Takei
    Cancer diagnosis & prognosis, 2021年
  • 難治性免疫・アレルギー疾患の病態の解明と新規治療法の開発
    岡山 吉道; 佐野 有隆; 豊島 翔太; 三木 寿美; 武富 芳隆; 坂本 朋美; 李 賢鎬; 齋藤 修; 村上 誠; 田杭 真帆; 伊東 真奈; 遠藤 嵩大; 丹羽 悠介; 葉山 惟大; 藤田 秀樹; 高橋 宏通; 三浦 勝浩; 濱田 岳志; 中川 優; 飯塚 和秀; 内野 慶人; 入山 規良; 小池 隆; 栗原 一也; 都築 広; 長澤 洋介; 長塚 靖子; 岩田 光浩; 北村 登; 丸岡 秀一郎; 福田 麻佐美; 山田 志保; 黒澤 雄介; 伊藤 亮治; 八田 善弘; 中山 智祥; 武井 正美; 徳橋 泰明; 權 寧博; 照井 正
    日本大学医学部総合医学研究所紀要, 2020年12月
  • びまん性大細胞型B細胞リンパ腫への形質転換をきたしたCD5陽性節性濾胞辺縁帯リンパ腫
    小池 隆; 入山 規良; 中川 優; 高橋 宏通; 濱田 高志; 内野 慶人; 三浦 勝浩; 八田 善弘; 中山 智祥; 武井 正美
    臨床血液, 2020年03月
  • Increased Arbekacin Clearance in Patients With Febrile Neutropenia.
    Takahiro Nakayama; Masayuki Chuma; Naohiro Tochikura; So Iwabuchi; Shinichiro Suzuki; Chiaki Matsumoto; Toru Imai; Takashi Hamada; Masaru Nakagawa; Hiromichi Takahashi; Yoshihito Uchino; Katsuhiro Miura; Noriyoshi Iriyama; Yoshihiro Hatta; Masami Takei; Takahisa Kimura
    Therapeutic drug monitoring, 2020年02月, 査読有り, 通常論文
  • [Transformation of CD5-positive nodal marginal zone lymphoma to diffuse large B-cell lymphoma].
    Takashi Koike; Noriyoshi Iriyama; Masaru Nakagawa; Hiromichi Takahashi; Takashi Hamada; Yoshihito Uchino; Katsuhiro Miura; Yoshihiro Hatta; Tomohiro Nakayama; Masami Takei
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2020年
  • Aggressive CD4-CD8-CD45RA+CCR10- Primary Cutaneous Peripheral T-cell Lymphoma, Not Otherwise Specified: A Case Report.
    Natsumi Ikumi; Hideki Fujita; Tadashi Terui; Hiromichi Takahashi; Katsuhiro Miura; Yoshihiro Hatta; Masami Takei
    Acta dermato-venereologica, 2019年11月, 査読有り, 通常論文
  • 特徴的な染色体転座を有するALL細胞の変異遺伝子の解析
    内野 慶人; 濱田 高志; 高橋 宏通; 入山 規良; 八田 善弘; 中山 智祥; 武井 正美
    日大医学雑誌, 2019年08月
  • MPC-1 expression in myeloma cells is associated with the efficacy of bortezomib therapy.
    Kazuya Kurihara; Noriyoshi Iriyama; Katsuhiro Miura; Yoshihito Uchino; Hiromichi Takahashi; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Takashi Koike; Yoshihiro Hatta; Tomohiro Nakayama; Masami Takei
    Medical oncology (Northwood, London, England), 2019年07月, 査読有り, 通常論文
  • [Acute sensory neuropathy associated with Hodgkin's lymphoma: a case study].
    Yuki Yokota; Kazutaka Mitsuke; Hiroko Minami; Akihiko Morita; Hiromichi Takahashi; Satoshi Kamei
    Rinsho shinkeigaku = Clinical neurology, 2019年06月
  • Conjunctival lymphomas in Japanese monozygotic twins: A case report.
    Naoya Ishibashi; Satoshi Sugaya; Hiromichi Takahashi; Haruna Nishimaki; Yoko Nakanishi; Yoshiaki Chinen; Toshiya Maebayashi
    Oncology letters, 2019年01月
  • Thrombopoietin Levels During Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia.
    Takashi Hamada; Noriyoshi Iriyama; Hiromichi Takahashi; Katsuhiro Miura; Yoshihito Uchino; Masaru Nakagawa; Yoshihiro Hatta; Masami Takei
    Clinical drug investigation, 2018年09月, 査読有り, 通常論文
  • 少量pomalidomideでstringent complete responseに到達した多発性骨髄腫
    遠藤聖英; 濱田高志; 大竹志門; 中川 優; 内野慶人; 高橋宏通; 三浦勝浩; 入山規良; 小池 隆; 栗原一也; 佐藤紘子; 八田善弘; 武井正美
    臨床血液, 2018年05月, 査読有り, 通常論文
  • Enhanced perforin expression associated with dasatinib therapy in natural killer cells.
    Noriyoshi Iriyama; Hiromichi Takahashi; Katsuhiro Miura; Yoshihito Uchino; Masaru Nakagawa; Yoshihiro Hatta; Masami Takei
    Leukemia research, 2018年05月, 査読有り, 通常論文
  • One percent chlorhexidine-alcohol for preventing central venous catheter-related infection during intensive chemotherapy for patients with haematologic malignancies.
    Shimon Ohtake; Hiromichi Takahashi; Masaru Nakagawa; Yoshihito Uchino; Katsuhiro Miura; Noriyoshi Iriyama; Tomohiro Nakayama; Yoshihiro Hatta; Masami Takei
    Journal of infection and chemotherapy, 2018年04月, 査読有り, 通常論文
    筆頭著者
  • Impact of interventions by an antimicrobial stewardship program team on appropriate antimicrobial therapy in patients with bacteremic urinary tract infection.
    Mitsuru Yanai; Maiko Ogasawara; Yuta Hayashi; Kiyozumi Suzuki; Hiromichi Takahashi; Atsushi Satomura
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018年03月
  • The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis.
    Naoto Tomita; Masahiro Yokoyama; Wataru Yamamoto; Reina Watanabe; Yutaka Shimazu; Yasufumi Masaki; Saburo Tsunoda; Chizuko Hashimoto; Kayoko Murayama; Takahiro Yano; Rumiko Okamoto; Ako Kikuchi; Kazuo Tamura; Kazuya Sato; Kazutaka Sunami; Hirohiko Shibayama; Rishu Takimoto; Rika Ohshima; Hiromichi Takahashi; Yukiyoshi Moriuchi; Tomohiro Kinoshita; Masahide Yamamoto; Ayumi Numata; Hideaki Nakajima; Ikuo Miura; Kengo Takeuchi
    Leukemia & lymphoma, 2018年01月
  • Retrospective evaluation of the clinical characteristics associated with Corynebacterium species bacteremia.
    Mitsuru Yanai; Maiko Ogasawasa; Yuta Hayashi; Kiyozumi Suzuki; Hiromichi Takahashi; Atsushi Satomura
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2018年
  • [Achievement of a stringent complete response with low-dose pomalidomide monotherapy in a multiple myeloma patient].
    Toshihide Endo; Takashi Hamada; Shimon Otake; Masaru Nakagawa; Yshihito Uchino; Hiromichi Takahashi; Katsuhiro Miura; Noriyoshi Iriyama; Takashi Koike; Kazuya Kurihara; Hiroko Sato; Yoshihiro Hatta; Msamai Takei
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2018年
  • Clinical effect of immunophenotyping on the prognosis of multiple myeloma patients treated with bortezomib.
    Noriyoshi Iriyama; Katsuhiro Miura; Yoshihiro Hatta; Sumiko Kobayashi; Yoshihito Uchino; Daisuke Kurita; Hitomi Sakagami; Hiromichi Takahashi; Masashi Sakagami; Yujin Kobayashi; Masaru Nakagawa; Shimon Ohtake; Yoshikazu Iizuka; Masami Takei
    Oncology letters, 2017年05月, 査読有り, 通常論文
  • 1α-Dihydroxyvitamin D3 and retinoic acid increase nuclear vitamin D receptor expression in monocytic THP-1 cells
    Hikaru Uchida; Yuichiro Hasegawa; Hiromichi Takahashi; Makoto Makishima
    Anticancer Research, 2016年12月, 査読有り, 通常論文
  • A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.
    Kurita D; Takeuchi K; Kobayashi S; Hojo A; Uchino Y; Sakagami M; Ohtake S; Takahashi H; Miura K; Iriyama N; Sugitani M; Miyoshi H; Hatta Y; Ohshima K; Takei M
    Virchows Archiv : an international journal of pathology, 2016年10月, 査読有り, 通常論文
  • Plasma cell maturity as a predictor of prognosis in multiple myeloma
    Noriyoshi Iriyama; Katsuhiro Miura; Yoshihiro Hatta; Yoshihito Uchino; Daisuke Kurita; Hiromichi Takahashi; Hitomi Sakagami; Masashi Sakagami; Yujin Kobayashi; Masaru Nakagawa; Shimon Ohtake; Yoshikazu Iizuka; Masami Takei
    MEDICAL ONCOLOGY, 2016年08月, 査読有り, 通常論文
  • Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy.
    Takahashi H; Miura K; Nakagawa M; Sugitani M; Amano Y; Kurita D; Sakagami M; Ohtake S; Uchino Y; Kodaira H; Iriyama N; Kobayashi S; Hojo A; Kobayashi Y; Hirabayashi Y; Kusuda M; Hatta Y; Nakayama T; Takei M.
    Leukemia and Lymphoma, 2016年04月, 査読有り, 通常論文
    筆頭著者
  • Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies
    Katsuhiro Miura; Masaru Nakagawa; Hiromichi Takahashi; Yoshihito Uchino; Hitomi Kodaira; Noriyoshi Iriyama; Masashi Sakagami; Shimon Ohtake; Sumiko Kobayashi; Atsuko Hojo; Daisuke Kurita; Yujin Kobayashi; Machiko Kusuda; Yukio Hirabayashi; Yoshihiro Hatta; Masami Takei
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016年03月, 査読有り, 通常論文
  • Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy.
    Miura K; Takahashi H; Nakagawa M; Izu A; Sugitani M; Kurita D; Sakagami M; Ohtake S; Uchino Y; Hojo A; Kodaira H; Yagi M; Kobayashi Y; Iriyama N; Kobayashi S; Kiso S; Hirabayashi Y; Hatta Y; Takei M.
    Leukemia and Lymphoma, 2015年10月, 査読有り, 通常論文
  • Higher Red Blood Cell Distribution Width Is an Adverse Prognostic Factor in Chronic-phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors.
    Iriyama N; Hatta Y; Kobayashi S; Uchino Y; Miura K; Kurita D; Kodaira H; Takahashi H; Iizuka Y; Inoue M; Takei M
    Anticancer research, 2015年10月, 査読有り, 通常論文
  • Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma.
    Kurita D; Miura K; Nakagawa M; Ohtake S; Sakagami M; Uchino Y; Takahashi H; Kiso S; Hojo A; Kodaira H; Yagi M; Hirabayashi Y; Kobayashi Y; Iriyama N; Kobayashi S; Hatta Y; Kura Y; Sugitani M; Takei M
    Int J Hematol., 2015年06月, 査読有り, 通常論文
  • Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma.
    Kobayashi Y; Hatta Y; Sugitani M; Hojo A; Nakagawa M; Kusuda M; Uchino Y; Takahashi H; Kiso S; Hirabayashi Y; Yagi M; Kodaira H; Kurita D; Miura K; Iriyama N; Kobayashi S; Kura Y; Horikoshi A; Sawada U; Takeuchi J; Takei M
    Leuk Lymphoma, 2014年11月, 査読有り, 通常論文
  • Diagnostic value of brain biopsy in intravascular large B-cell lymphoma mimicking progressive multifocal leukoencephalopathy: Case report
    Yusuke Takamine; Natsumi Ikumi; Hajime Onoe; Misa Hayase; Yousuke Nagasawa; Masashi Sakagami; Kaita Sugiyama; Suguru Nakahawa; Yoshito Uchino; Hiromichi Takahashi; Yukio Hirabayashi; Takamasa Nozaki; Katsuhiro Miura; Hirotake Inomata; Noriyoshi Iriyama; Hidetaka Shiraiwa; Sumiko Kobayashi; Noboru Kitamura; Yoshihiro Hatta; Yoshihiro Matsukawa; Masami Takei
    Japanese Journal of Clinical Immunology, 2014年, 査読有り, 通常論文
  • Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas
    Noriyoshi Iriyama; Hiromichi Takahashi; Yoshihiro Hatta; Katsuhiro Miura; Yujin Kobayashi; Daisuke Kurita; Yukio Hirabayashi; Atsuko Hojo; Hitomi Kodaira; Mai Yagi; Satomi Kiso; Yoshihito Uchino; Masaru Nakagawa; Machiko Kusuda; Sumiko Kobayashi; Akira Horikoshi; Yoshimasa Kura; Tetsuo Yamazaki; Umihiko Sawada; Jin Takeuchi
    ONCOLOGY REPORTS, 2013年02月, 査読有り, 通常論文
  • Efficacy of oral cytarabine ocfosfate and Etoposide in the treatment of elderly patients with higher-risk myelodysplastic syndromes compared to that in elderly acute myeloid leukemia patients.
    Horikoshi A; Iriyama N; Hirabayashi Y; Kodaira H; Matsukawa Y; Uchino Y; Takahashi H; Hatta Y; Takeuchi J; Kobayashi S; Miura K
    Chemotherapy, 2013年, 査読有り, 通常論文
  • [Pathology of acute lymphoblastic leukemia].
    Takahashi H; Takeuchi J
    Nihon rinsho. Japanese journal of clinical medicine, 2012年04月, 査読有り, 通常論文
  • Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOP.
    Kobayashi Y; Hatta Y; Hojo A; Kura Y; Uchino Y; Takahashi H; Kiso S; Hirabayashi Y; Yagi M; Kodaira H; Kurita D; Tanaka T; Miura K; Iriyama N; Kobayashi S; Sawada U; Sugitani M; Takeuchi J
    Experimental and Therapeutic Medicine, 2012年02月, 査読有り, 通常論文

MISC

  • A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31).
    Noriyoshi Iriyama; Hiromichi Takahashi; Hiromu Naruse; Katsuhiro Miura; Yoshihito Uchino; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Yoshihiro Hatta; Tomohiro Nakayama; Masami Takei
    Molecular genetics & genomic medicine, 2019年04月07日, 査読有り, 通常論文
    筆頭著者
  • Clinical Significance of Co-Expression of MYC and BCL2 Protein in Advanced Diffuse Large B-Cell Lymphoma Treated with a Dose-Intensified Immunochemotherapy
    Hiromichi Takahashi; Sumiko Kobayashi; Katsuhiro Miura; Daisuke Kurita; Yoshihiro Hatta; Masahiko Sugitani; Shimon Otake; Masaru Nakagawa; Masashi Sakagami; Yoshihito Uchino; Hitomi Kodaira; Noriyoshi Iriyama; Machiko Kusuda; Atsuko Hojo; Mai Yagi; Yukio Hirabayashi; Yujin Kobayashi; Tomohiro Nakayama; Masami Takei
    BLOOD, 2015年12月, 査読無し, 通常論文
  • Induced differentiation of human myeloid leukemia cells into M2 macrophages by combined treatment with retinoic acid and 1α,25-dihydroxyvitamin D3.
    Takahashi H; Hatta Y; Iriyama N; Hasegawa Y; Uchida H; Nakagawa M; Makishima M; Takeuchi J; Takei M
    PLoS One, 2015年11月19日, 査読有り, 通常論文
    筆頭著者
  • 【造血幹細胞移植(内科領域)】リンパ腫と造血幹細胞移植 当施設の治療経験も含めて
    高橋 宏通; 中山 智祥
    日大医学雑誌, 2015年10月01日, 査読有り, 通常論文
  • Clinical Significance of Arbekacin Sulfate for High-Risk Infections Among Patients with Hematological Malignancies
    Katsuhiro Miura; Satomi Kiso; Masaru Nakagawa; Hiromichi Takahashi; Yoshito Uchino; Hitomi Kodaira; Noriyoshi Iriyama; Masashi Sakagami; Shimon Ohtake; Sumiko Kobayashi; Atsuko Hojo; Mai Yagi; Daisuke Kurita; Yujin Kobayashi; Machiko Kusuda; Yukio Hirabayashi; Yoshihiro Hatta; Masami Takei
    BLOOD, 2014年12月, 査読無し, 通常論文
  • Efficacy of a Dose-Intensified CHOP (Double-CHOP) Regimen for Peripheral T-Cell Lymphomas
    Hiromichi Takahashi; Noriyoshi Iriyama; Yoshihiro Hatta; Katsuhiro Miura; Yujin Kobayashi; Daisuke Kurita; Yukio Hirabayashi; Atsuko Hojo; Hitomi Kodaira; Mai Yagi; Satomi Kiso; Yoshihito Uchino; Masaru Nakagawa; Machiko Kusuda; Sumiko Kobayashi; Akira Horikoshi; Yoshimasa Kura; Tetsuo Yamazaki; Umihiko Sawada; Jin Takeuchi
    BLOOD, 2012年11月, 査読無し, 通常論文
  • Obesity Is a Poor Prognostic Factor In Acute Promyelocytic Leukemia (APL)
    Yoshihiro Hatta; Akira Horikoshi; Daisuke Kurita; Sumiko Kobayashi; Yujin Kobayashi; Yoshimasa Kura; Hitomi Kodaira; Yasuyuki Inoue; Katsuhiro Miura; Satomi Kiso; Hiromichi Takahashi; Hikari Ishizuka; Toshitake Tanaka; Mai Yagi; Atsuko Hojo; Yukio Hirabayashi; Yoshihito Uchino; Noriyoshi Iriyama; Umihiko Sawada; Jin Takeuchi
    BLOOD, 2010年11月, 査読無し, 通常論文

書籍等出版物

  • 造血器腫瘍学 2012年70巻増刊号2(4月発行) 急性リンパ性白血病の病因・病態
    共著, 髙橋宏通、竹内仁
    日本臨床, 2012年04月
  • 造血器腫瘍学 2012年70巻増刊号2(4月発行)急性リンパ性白血病の病因・病態
    髙橋宏通; 竹内仁, 共著
    日本臨床, 2012年04月, 査読無し

講演・口頭発表等

  • 未治療進行期末梢性T細胞リンパ腫へのDouble-THP-COP療法と大量化学療法による地固め療法
    高橋宏通、三浦勝浩、中川優、内野慶人、伊藤 駿、忽滑谷寛直、栗原一也、遠藤聖英、小池 隆、濱田高志、飯塚和秀、入山規良、八田善弘、中山智祥、武井正美
    第82回日本血液学会学術集会, 2020年10月, 通常論文
  • アファチニブが奏功したEGFR exon19欠失を伴う原発不明腺癌の一例
    第16回日本臨床腫瘍学会学術集会, 2018年07月, 通常論文
  • 新規薬剤時代における多発性骨髄腫に対する大量エトポシドを用いたPBSCCの有効性、安全性の検討
    第40回日本造血細胞移植学会総会, 2018年02月, 通常論文
  • 進行期高悪性度リンパ腫に対する超大量メソトレキセート療法の有効性、安全性の検討
    髙橋宏通
    第78回日本血液学会学術集会, 2016年10月, 通常論文
  • Clinical Significance of Co-Expression of MYC and BCL2 Protein in Advanced Diffuse Large B-Cell Lymphoma Treated with a Dose-Intensified Immunochemotherapy
    Hiromichi Takahashi
    第57回米国血液学会総会, 2015年12月, 通常論文
  • マントル細胞リンパ腫における強化CHOP療法(R-Double-CHOP)と地固め療法としての自家末梢血造血幹細胞移植療法の有効性、安全性の検討
    髙橋宏通
    第77回日本血液学会学術集会, 2015年10月, 通常論文

共同・受託研究希望テーマ

  • リンパ腫における臨床研究全般, 産学連携等、民間を含む他機関等との共同研究を希望, 共同研究

共同研究・競争的資金等の研究課題

  • ホジキンリンパ腫における多重蛍光染色を用いた腫瘍微小環境の同定と予後に与える影響
    日本学術振興会, 科学研究費助成事業, 2020年05月 - 2022年12月
    高橋 宏通